|
2014
|
Invention
|
Tetrasubstituted benzenes.
Tetrasubstituted benzenes that act as modulators of gamma secretase a... |
|
2013
|
Invention
|
1,3,4-trisubstituted benzenes.
Compounds that are 1,3,4-trisubstituted benzenes which modulate (... |
|
|
Invention
|
Pde-10 inhibitors.
Vicinal substituted cyclopropyl compounds which are inhibitors of phosphodies... |
|
|
Invention
|
Imidazotriazinone compounds. The present invention provides imidazotriazinone compounds which are... |
|
|
Invention
|
Tetrasubstituted benzenes. Tetrasubstituted benzenes that act as modulators of gamma secretase an... |
|
|
Invention
|
Tetrasubstituted benzenes. Provided herein are tetrasubstituted benzenes that act as modulators o... |
|
|
Invention
|
Tetrasubstituted benzenes for treatment of early onset alzheimer's disease. Provided are composit... |
|
2012
|
Invention
|
Methods of treatment of limited cognitive impairment. A method for improving or treating a Limite... |
|
|
Invention
|
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combina... |
|
|
Invention
|
Methods of targeted treatment of frontotemporal lobar degeneration. The present invention provide... |
|
2011
|
Invention
|
Treatment of inflammation with certain alpha-7 nicotinic acid receptor agonists in combination wi... |
|
|
Invention
|
Imidazotriazinone compounds.
The present invention provides imidazotriazinone compounds which ar... |
|
|
Invention
|
A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochlor... |
|
2010
|
Invention
|
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination wit... |
|
2009
|
Invention
|
Phenoxymethyl heterocyclic compounds. Phenoxymethyl compounds that inhibit at least one phosphodi... |
|
|
Invention
|
Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carbox... |
|
|
Invention
|
Pde-10 inhibitors. Vicinal substituted cyclopropyl compounds which are inhibitors of phosphodiest... |
|
|
Invention
|
Di-substituted phenyl compounds.
Di-substituted phenyl compounds which are inhibitors of phospho... |
|
|
Invention
|
Di-substituted phenyl compounds. Di-substituted phenyl compounds which are inhibitors of phosphod... |
|
|
Invention
|
5- and 6-membered heterocyclic compounds. 5- and 6- membered heterocyclic compounds which are inh... |
|
|
Invention
|
Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors. Di-substituted phenyl compoun... |
|
|
Invention
|
1, 2 disubstituted heterocyclic compounds. 1,2-disubstituted heterocyclic compounds which are inh... |
|
|
Invention
|
Inhibitors of histone deacetylase. Compounds which are histone deacetylase inhibitors and their u... |
|
|
Invention
|
Hdac inhibitors and uses thereof. Inhibitors of histone deacetylase, including compounds having a... |
|
|
Invention
|
Methods for treating cognitive disorders using inhibitors of histone deacetylase. This disclosure... |
|
2008
|
Invention
|
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders.
The pres... |
|
|
Invention
|
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders. The prese... |
|
|
Invention
|
1,3,4-trisubstituted benzenes. Compounds that are 1,3,4-trisubstituted benzenes which modulate (e... |
|
2007
|
Invention
|
Method of treating neurological disorders with carbonic anhydrase inhibitors. Described herein ar... |
|
|
Invention
|
Inhibitors of histone deacetylase. This invention relates to compounds for the inhibition of hist... |
|
|
Invention
|
Quinoline derivatives. The invention relates to new quinoline derivatives which are active CLK-1 ... |
|
|
Invention
|
Transgenic flies expressing tau and amyloid precursor fragment. The present invention discloses a... |
|
2006
|
Invention
|
Device and method for automated transfer of small organisms.
A device is disclosed for transferr... |
|
|
Invention
|
Device and method for automated transfer of small organisms. A device is disclosed for transferri... |
|
2003
|
G/S
|
Pharmaceutical preparations for the treatment of the central nervous system namely, central nervo... |
